What is the ticker symbol for Aeglea BioTherapeutics?

Aeglea BioTherapeutics trades under the ticker AGLE on NASDAQ.

What sector does Aeglea BioTherapeutics operate in?

Aeglea BioTherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AGLE in a portfolio?

PortView shows AGLE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Aeglea BioTherapeutics (AGLE) Stock Analysis

NASDAQHealthcareBiotechnology

$12.01+6.66%

1-year price historyRange $2.65 – $20.50

52-week range$12.01

$2.66$24.00

What Aeglea BioTherapeutics does

Aeglea BioTherapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating human enzyme therapies for rare metabolic diseases. Their leading candidate, pegzilarginase, a recombinant human Arginase 1, is currently in the pivotal Phase III PEACE trial to assess its safety and effectiveness for treating Arginase 1 deficiency. Furthermore, the company is developing AGLE-177, a polyethylene glycol modified enzyme, which is progressing through Phase I/II clinical trials for homocystinuria. Their early-stage pipeline includes AGLE-325 for cystinuria, along with other ongoing research initiatives. Founded in 2013, the company was initially known as Aeglea BioTherapeutics Holdings, LLC, changing its name to Aeglea BioTherapeutics, Inc. in March 2015. It is based in Austin, Texas.

Key metrics

Market cap

$48.63M

P/E (TTM)

-0.16

EPS (TTM)

$-74.15

Beta

2.57

Dividend yield

0.00%

Revenue / share

$1.07

50-day avg

$12.64

200-day avg

$9.84

52-week high

$24.00

52-week low

$2.66

CEO

Jonathan D. Alspaugh

ETFs linked to AGLE

Broad-market and Healthcare sector ETFs an investor holding Aeglea BioTherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AGLE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AGLE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Aeglea BioTherapeutics?: Aeglea BioTherapeutics trades under the ticker AGLE on NASDAQ.
Which exchange is AGLE listed on?: AGLE is listed on NASDAQ.
What sector does Aeglea BioTherapeutics operate in?: Aeglea BioTherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AGLE in a portfolio?: PortView shows AGLE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.